Cellular Therapy · Clinical
Muse Cell Therapy: Uses, Access & What Doctors Should Know
A working overview of Muse cell therapy for physicians evaluating Dezawa-lineage stem cell platforms — indications, patient access, cost drivers, safety, and how the summit faculty integrate it into real practice.
Clinical applications
- Orthopedic injury and joint recovery
- Neurologic indications — stroke, spinal cord injury (Japan trials)
- Cardiac and hepatic repair (early clinical work)
- Systemic longevity, immune modulation, and inflammatory protocols
- Regenerative aesthetics with MuseExosomes for skin and scalp
Cost & access
Muse cell therapy pricing is driven by sourcing, dose, delivery format, and jurisdiction. Physician-administered systemic protocols typically run in the thousands per session in the US. Aesthetic MuseExosome protocols are priced per treatment. There is no single list price — always request batch documentation and licensing chain from any vendor.
Safety & regulatory
Muse cells are non-tumorigenic in preclinical studies and exit the cell cycle after differentiation. Regulatory status varies by jurisdiction — US physicians should evaluate each product against 21 CFR 1271 (HCT/Ps) and equivalent local frameworks before use.
Frequently asked questions
What is Muse cell therapy?
Muse cell therapy uses Dezawa-lineage SSEA-3+ pluripotent-like stem cells — infused, injected, or applied — to support tissue repair, systemic longevity protocols, and regenerative aesthetics. Because Muse cells home to injury via S1P signaling, they concentrate at damaged tissue.
What conditions is Muse cell therapy used for?
Investigational and clinical uses include orthopedic recovery, neurologic indications (stroke, spinal cord injury — trials in Japan), cardiac and hepatic repair, systemic longevity protocols, and regenerative aesthetics when paired with MuseExosomes.
How much does Muse cell therapy cost?
Cost varies by indication, dose, sourcing, and jurisdiction. Physician-administered protocols in the US typically run in the thousands of dollars per session; aesthetic MuseExosome protocols are priced per treatment. There is no fixed list price — sourcing and licensing drive most of the variability.
Is Muse cell therapy FDA approved?
Muse cell products are in clinical development. In the US, cellular therapies are regulated under FDA rules (21 CFR 1271 / HCT/Ps), and physicians should confirm the regulatory status of any specific product in their jurisdiction before use. Aesthetic MuseExosome preparations are typically labeled for professional topical use.
Where can doctors learn to offer Muse cell therapy?
The Regenerative Medicine Summit teaches physicians how to source, evaluate, and integrate Muse cell and MuseExosome protocols into practice, with faculty including Dr. Pradeep Albert and Dr. Matt Cook.